untitled
|
|
- まれあ あくや
- 5 years ago
- Views:
Transcription
1
2 Data cleaning Original datan=8479 NCC/ptkgN=7958 NCC10x10E NCC/kgPage 1-2) Covariate cleaningcovariate Page Page5-8
3 Kaplan-Meier method, Log-rank, Cox hazard model Overall survival Cumulative incidence method, Gray test, Competing hazard regression model PltRet /GVHD Logistic model PltRet
4 Patient characteristics (n=8139) NCC/kg Total Adult 1,134 2,775 2, ,763 Child ,376 Total 1,253 3, 080 2,677 1,129 8,139 Frequency Adult ( , med2.81) NCC/Pt kg Excel) Frequency Child ( , med3.51) NCC/Pt kg
5 Neu500 Adult Cumulative incidence (n=5020) Probability P< % d % d % d % d Days
6 Neu500 Adult Cumulative incidence (n=4981) Benign (n=206) Malignancy (n=4775) % d 93.0% d 97.1% d 100 % d % d 97.5% d 99.1% d 99.2 % d
7 Neu500 Child Cumulative incidence (n=1320) Probability P= % d % d % d % d Days
8 Neu500 Child Cumulative incidence (n=1320) Benign (n=245) Malignancy (n=1075) % d % d % d % d16 P= % d % d % d % d17 P= Days Days
9 Plt5 Adult Cumulative incidence (n=5039) Probability P< % d % d % d % d Days
10 Plt5 Child Cumulative incidence (n=1323) Probability P< % d % d % d % d Days
11 Ret1 Adult Cumulative incidence (n=5039) Probability P< % d % d % d % d Days
12 Ret1 Child Cumulative incidence (n=1323) Probability P< % d % d % d % d Days
13 OS (n=314) Adult/ Benign (n=19) Child/ Benign (n=9) Adult/ Malignancy (n=251) Child/ Malignancy (n=35) Days after SCT
14 Adult Overall survival (N=5096) Kaplan-Meier survival estimates P= analysis time cd cd cd cd
15 Adult Overall survival (N=4868) cd = /H cd = /H cd = /H cd = /H cd = /S cd = /S cd = /S cd = /S Months after SCT
16 Adult Overall survival Benign disease (n=209) Malignant disease (n=4859) cd = cd = cd = cd = cd = /H cd = /H cd = /H cd = /H cd = /S cd = /S cd = /S cd = /S Months after SCT Months after SCT
17 Children Overall survival (N=1332) Kaplan-Meier survival estimates P= analysis time cd cd cd cd
18 Children Overall survival (N=1245) cd = /H cd = /H cd = /H cd = /H cd = /S cd = /S cd = /S cd = /S Months after SCT
19 Children Overall survival Benign disease (n=247) Malignant disease (n=1067) cd = /H cd = /S cd = cd = cd = cd = Months after SCT cd = /H cd = /S cd = /H cd = /S cd = /H cd = /S Months after SCT
20 NRM & Relapse Adult Cumulative incidence (n=4836) Probability Months after SCT NRM Relapse 43% 23% 39% 21% 42% 19% 33% 18% NRM (P=0.024) Relapse (P=0.10)
21 Probability NRM Child Cumulative incidence (n=1273) Months after SCT NRM 37% 25% 23% 21% NRM (P=0.013)
22 Relapse Child Cumulative incidence (n=1273) Probability Relapse 22% 20% 22% 19% Relapse (P=0.83) Months after SCT
23 agvhdi Adult Cumulative incidence (n=4741) Probability P= (Gray test) 65.4% 67.9% 69.0% 70.8% Months after SCT
24 agvhdii Adult Cumulative incidence (n=4741) Probability % 43.8% 43.1% 43.0% P=0.808 (Gray test) Months after SCT
25 agvhdiii Adult Cumulative incidence (n=4741) Probability P=0.466 (Gray test) 17.0% 18.0% 19.4% 18.4% Months after SCT
26 agvhdi Child Cumulative incidence (n=1261) Probability P= (Gray test) 62.4% 70.4% 74.4% 68.4% Months after SCT
27 agvhdii Child Cumulative incidence (n=1261) Probability % 50.0% 45.2% 46.0% P= (Gray test) Months after SCT
28 agvhdiii Child Cumulative incidence (n=1261) Probability % 20.1% 22.8% 22.6% P=0.760 (Gray test) Months after SCT
29 cgvhd(lm+ex) Adult Cumulative incidence (n=3725) Probability % 44.0% 43.0% 46.7% P=0.45 (Gray test) Months after day100
30 cgvhd(lm/ex) Adult Cumulative incidence (n=3725) Probability LM EX LM EX 16.7% 29.5% 16.1% 27.9% 14.0% 29.0% 15.1% 31.7% P=0.31 P=0.54 (Gray test) Months after day100
31 cgvhd(lm+ex) Child Cumulative incidence (n=1075) Probability % 32.2% 33.6% 33.4% P=0.99 (Gray test) Months after day100
32 cgvhd(lm/ex) Child Cumulative incidence (n=1075) Probability LM EX LM EX 15.8% 18.2% 15.5% 16.7% 13.0% 20.6% 14.9% 18.5% P=0.81 P=0.72 (Gray test) Months after day100
33 30Early death Adult P=0.626) Children P=0.194)
34 Ret NRM (Cox Grade IGVHDHR 1.061)Grade II-IV, III-IV GVHD 30 NRM GVHDaGVHD 4x10 8 /kggvhd GVHD Competing hazardcox
35 TBIFK MinorMajorTCD) HLAGVHD -2 Logistic model TBI HLA rejection
36 TBI HLARejection FK Ret HLA
37 FK HLA Rejection NRM FK HLA Rejection HLAGVHD VPFK Cox
38 Grade IGVHD HLAGVHDTBI RISTFK Grade II-IVGVHD HLAGVHD Grade III-IVGVHD HLA GVHD FK GVHDLM+EX) DnPtTBIGradeI agvhdgradeiiagvhd
39 11. HLAGVHD 12. HLAGVHD 13. HLAGVHD DnPt TBI FK 14. T HLAGVHD RIST FK THLAGVHD
40
41
42
43
44 2x10 8 /Pt.kg (x10 8 /Pt.kg) 1x10 8 /Pt.kg6 37.5kg
45 400 2x10 8 /Pt.kg
46 +400ml
「産業上利用することができる発明」の審査の運用指針(案)
1 1.... 2 1.1... 2 2.... 4 2.1... 4 3.... 6 4.... 6 1 1 29 1 29 1 1 1. 2 1 1.1 (1) (2) (3) 1 (4) 2 4 1 2 2 3 4 31 12 5 7 2.2 (5) ( a ) ( b ) 1 3 2 ( c ) (6) 2. 2.1 2.1 (1) 4 ( i ) ( ii ) ( iii ) ( iv)
More information44 4 I (1) ( ) (10 15 ) ( 17 ) ( 3 1 ) (2)
(1) I 44 II 45 III 47 IV 52 44 4 I (1) ( ) 1945 8 9 (10 15 ) ( 17 ) ( 3 1 ) (2) 45 II 1 (3) 511 ( 451 1 ) ( ) 365 1 2 512 1 2 365 1 2 363 2 ( ) 3 ( ) ( 451 2 ( 314 1 ) ( 339 1 4 ) 337 2 3 ) 363 (4) 46
More informationi ii i iii iv 1 3 3 10 14 17 17 18 22 23 28 29 31 36 37 39 40 43 48 59 70 75 75 77 90 95 102 107 109 110 118 125 128 130 132 134 48 43 43 51 52 61 61 64 62 124 70 58 3 10 17 29 78 82 85 102 95 109 iii
More informationi
14 i ii iii iv v vi 14 13 86 13 12 28 14 16 14 15 31 (1) 13 12 28 20 (2) (3) 2 (4) (5) 14 14 50 48 3 11 11 22 14 15 10 14 20 21 20 (1) 14 (2) 14 4 (3) (4) (5) 12 12 (6) 14 15 5 6 7 8 9 10 7
More information第1部 一般的コメント
(( 2000 11 24 2003 12 31 3122 94 2332 508 26 a () () i ii iii iv (i) (ii) (i) (ii) (iii) (iv) (a) (b)(c)(d) a) / (i) (ii) (iii) (iv) 1996 7 1996 12
More information表1票4.qx4
iii iv v 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 22 23 10 11 24 25 26 27 10 56 28 11 29 30 12 13 14 15 16 17 18 19 2010 2111 22 23 2412 2513 14 31 17 32 18 33 19 34 20 35 21 36 24 37 25 38 2614
More information第1章 国民年金における無年金
1 2 3 4 ILO ILO 5 i ii 6 7 8 9 10 ( ) 3 2 ( ) 3 2 2 2 11 20 60 12 1 2 3 4 5 6 7 8 9 10 11 12 13 13 14 15 16 17 14 15 8 16 2003 1 17 18 iii 19 iv 20 21 22 23 24 25 ,,, 26 27 28 29 30 (1) (2) (3) 31 1 20
More informationI? 3 1 3 1.1?................................. 3 1.2?............................... 3 1.3!................................... 3 2 4 2.1........................................ 4 2.2.......................................
More information20 15 14.6 15.3 14.9 15.7 16.0 15.7 13.4 14.5 13.7 14.2 10 10 13 16 19 22 1 70,000 60,000 50,000 40,000 30,000 20,000 10,000 0 2,500 59,862 56,384 2,000 42,662 44,211 40,639 37,323 1,500 33,408 34,472
More information- 2 -
- 2 - - 3 - (1) (2) (3) (1) - 4 - ~ - 5 - (2) - 6 - (1) (1) - 7 - - 8 - (i) (ii) (iii) (ii) (iii) (ii) 10 - 9 - (3) - 10 - (3) - 11 - - 12 - (1) - 13 - - 14 - (2) - 15 - - 16 - (3) - 17 - - 18 - (4) -
More information2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4 4 4 2 5 5 2 4 4 4 0 3 3 0 9 10 10 9 1 1
1 1979 6 24 3 4 4 4 4 3 4 4 2 3 4 4 6 0 0 6 2 4 4 4 3 0 0 3 3 3 4 3 2 4 3? 4 3 4 3 4 4 4 4 3 3 4 4 4 4 2 1 1 2 15 4 4 15 0 1 2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4
More information1 (1) (2)
1 2 (1) (2) (3) 3-78 - 1 (1) (2) - 79 - i) ii) iii) (3) (4) (5) (6) - 80 - (7) (8) (9) (10) 2 (1) (2) (3) (4) i) - 81 - ii) (a) (b) 3 (1) (2) - 82 - - 83 - - 84 - - 85 - - 86 - (1) (2) (3) (4) (5) (6)
More information23 3 11 14 46 9.0 7 10m 40.1m 15,883 2,681 25 4 10 39 40 800 180 24 2425 22 21 24 5 3 21 24 10,899 20,472 13,723 33,007 667 400 79,167 8,620 11,694 10,089 25,131 690 215 56,439 13,614 20,897 15,200 32,213
More informationprovider_020524_2.PDF
1 1 1 2 2 3 (1) 3 (2) 4 (3) 6 7 7 (1) 8 (2) 21 26 27 27 27 28 31 32 32 36 1 1 2 2 (1) 3 3 4 45 (2) 6 7 5 (3) 6 7 8 (1) ii iii iv 8 * 9 10 11 9 12 10 13 14 15 11 16 17 12 13 18 19 20 (2) 14 21 22 23 24
More informationi ii iii iv v vi vii ( ー ー ) ( ) ( ) ( ) ( ) ー ( ) ( ) ー ー ( ) ( ) ( ) ( ) ( ) 13 202 24122783 3622316 (1) (2) (3) (4) 2483 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) 11 11 2483 13
More informationJMP V4 による生存時間分析
V4 1 SAS 2000.11.18 4 ( ) (Survival Time) 1 (Event) Start of Study Start of Observation Died Died Died Lost End Time Censor Died Died Censor Died Time Start of Study End Start of Observation Censor
More informationChapter 1 Epidemiological Terminology
Appendix Real examples of statistical analysis 検定 偶然を超えた差なら有意差という P
More information178 5 I 1 ( ) ( ) 10 3 13 3 1 8891 8 3023 6317 ( 10 1914 7152 ) 16 5 1 ( ) 6 13 3 13 3 8575 3896 8 1715 779 6 (1) 2 7 4 ( 2 ) 13 11 26 12 21 14 11 21
I 178 II 180 III ( ) 181 IV 183 V 185 VI 186 178 5 I 1 ( ) ( ) 10 3 13 3 1 8891 8 3023 6317 ( 10 1914 7152 ) 16 5 1 ( ) 6 13 3 13 3 8575 3896 8 1715 779 6 (1) 2 7 4 ( 2 ) 13 11 26 12 21 14 11 21 4 10 (
More information橡災害.PDF
1 2 3 4 5 6 7 8 9 10 11 12 2.1 2.2 2.2.1 13 2.2.2 2.2.3 14 2.3 2.3.1 2.3.2 all or nothing 2.4. 2.4.1 15 i) ii) iii) iv) 2.5 2.4.2 2.2 2.5 2.5.1 16 2.5.2 2.6 2.6.1 2.4 2.6.2 2.6.3 2.6.4 17 18 3.2.1 Hazard
More informationuntitled
twatanab@oncoloplan.com http://www.oncoloplan.com I II - III IV Fig 3. Survival curves overall and according to response Bruzzi, P. et al. J Clin Oncol; 23:5117-5125 25 Copyright merican Society of Clinical
More informationuntitled
i ii iii iv v 43 43 vi 43 vii T+1 T+2 1 viii 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 a) ( ) b) ( ) 51
More informationAccessflÌfl—−ÇŠš1
ACCESS ACCESS i ii ACCESS iii iv ACCESS v vi ACCESS CONTENTS ACCESS CONTENTS ACCESS 1 ACCESS 1 2 ACCESS 3 1 4 ACCESS 5 1 6 ACCESS 7 1 8 9 ACCESS 10 1 ACCESS 11 1 12 ACCESS 13 1 14 ACCESS 15 1 v 16 ACCESS
More information2
1 2 3 4 5 6 7 8 9 10 I II III 11 IV 12 V 13 VI VII 14 VIII. 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 _ 33 _ 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 VII 51 52 53 54 55 56 57 58 59
More informationd-00
283-0105 298 TEL. 0475-76-0839 FAX. 0475-76-0838 400g 300 4950399167708 14 220g 300 4950399066780 Page 1 300g 200 4950399066766 100 400g 300 4950399167722 350g 160 4950399066735 100 600g 350 4950399167685
More information262014 3 1 1 6 3 2 198810 2/ 198810 2 1 3 4 http://www.pref.hiroshima.lg.jp/site/monjokan/ 1... 1... 1... 2... 2... 4... 5... 9... 9... 10... 10... 10... 10... 13 2... 13 3... 15... 15... 15... 16 4...
More information10 2 2 10 6.5 78 1 65 / 30 / - 2 -
- 1 - 10 2 2 10 6.5 78 1 65 / 30 / - 2 - 3 3 30 8 4 8 6 11 14 45 14 7 8 1-3 - 4 1 () 20 4 9 4 9 3 9 4 PR 4 3-4 - - 5 - PR 15 4 PR 7 8 4 9 10-6 - 9 10 9 10 4 9 10 3 9 10 9 9 9 10 PR 1-7 - PR - 8 - 30 100-9
More information...J......1803.QX
5 7 9 11 13 15 17 19 21 23 45-1111 48-2314 1 I II 100,000 80,000 60,000 40,000 20,000 0 272,437 80,348 82,207 81,393 82,293 83,696 84,028 82,232 248,983 80,411 4,615 4,757 248,434 248,688 76,708 6,299
More information1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 () - 1 - - 2 - - 3 - - 4 - - 5 - 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57
More informationuntitled
- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - - 20 - - 21 - - 22 - - 23 - - 24 - - 25 - - 26 - - 27 - - 28 - - 29 - - 30 -
More information- - - - - - - - - - - - - - - - - - - - - - - - - -1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -2...2...3...4...4...4...5...6...7...8...
取 扱 説 明 書 - - - - - - - - - - - - - - - - - - - - - - - - - -1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -2...2...3...4...4...4...5...6...7...8...9...11 - - - - - - - - - - - - - - - - -
More informationito.dvi
1 2 1006 214 542 160 120 160 1 1916 49 1710 55 1716 1 2 1995 1 2 3 4 2 3 1950 1973 1969 1989 1 4 3 3.1 3.1.1 1989 2 3.1.2 214 542 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
More information86 7 I ( 13 ) II ( )
10 I 86 II 86 III 89 IV 92 V 2001 93 VI 95 86 7 I 2001 6 12 10 2001 ( 13 ) 10 66 2000 2001 4 100 1 3000 II 1988 1990 1991 ( ) 500 1994 2 87 1 1994 2 1000 1000 1000 2 1994 12 21 1000 700 5 800 ( 97 ) 1000
More informationBSE Excel
200 2 200311110 BSE Excel 1 3 11 1 21 2 20 1 26 2203 2 10 1718 485 13 2 2 6 100 371 12 3 100 679 1 12 2 9 1 29 2 10 1 1-1 2 /kg 1-2 3 1-3 2 http://www.maff.go.jp/ 3 Excel 2 15 1 26 2 2 9 16 1 30 2 10 1-4
More information入門ガイド
ii iii iv NEC Corporation 1998 v P A R 1 P A R 2 P A R 3 T T T vi P A R T 4 P A R T 5 P A R T 6 P A R T 7 vii 1P A R T 1 2 2 1 3 1 4 1 1 5 2 3 6 4 1 7 1 2 3 8 1 1 2 3 9 1 2 10 1 1 2 11 3 12 1 2 1 3 4 13
More information2 H23 BioS (i) data d1; input group patno t sex censor; cards;
H BioS (i) data d1; input group patno t sex censor; cards; 0 1 0 0 0 0 1 0 1 1 0 4 4 0 1 0 5 5 1 1 0 6 5 1 1 0 7 10 1 0 0 8 15 0 1 0 9 15 0 1 0 10 4 1 0 0 11 4 1 0 1 1 5 1 0 1 1 7 0 1 1 14 8 1 0 1 15 8
More information土壌環境行政の最新動向(環境省 水・大気環境局土壌環境課)
201022 1 18801970 19101970 19201960 1970-2 1975 1980 1986 1991 1994 3 1999 20022009 4 5 () () () () ( ( ) () 6 7 Ex Ex Ex 8 25 9 10 11 16619 123 12 13 14 5 18() 15 187 1811 16 17 3,000 2241 18 19 ( 50
More informationsyuryoku
248 24622 24 P.5 EX P.212 2 P271 5. P.534 P.690 P.690 P.690 P.690 P.691 P.691 P.691 P.702 P.702 P.702 P.702 1S 30% 3 1S 3% 1S 30% 3 1S 3% P.702 P.702 P.702 P.702 45 60 P.702 P.702 P.704 H17.12.22 H22.4.1
More informationi ii ( ) ( ) ( ) 462,891 525,032 502,164 230,636 CD CD 1 1 2 2 3 3 4 4 5 5 6 6 7 7 8 8 9 9 10 10 11 10 12 11 13 11 14 12 15 12 16 13 16 14 17 15 18 15 18 16 19 17 20 17 18 19
More informationSC-85X2取説
I II III IV V VI .................. VII VIII IX X 1-1 1-2 1-3 1-4 ( ) 1-5 1-6 2-1 2-2 3-1 3-2 3-3 8 3-4 3-5 3-6 3-7 ) ) - - 3-8 3-9 4-1 4-2 4-3 4-4 4-5 4-6 5-1 5-2 5-3 5-4 5-5 5-6 5-7 5-8 5-9 5-10 5-11
More information<4D6963726F736F667420506F776572506F696E74202D208376838C835B83938365815B835683878393312E707074205B8CDD8AB78382815B83685D>
i i vi ii iii iv v vi vii viii ix 2 3 4 5 6 7 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
More information2004/01/12 1 2004/01/23 2 I- - 10 2004/04/02 3-6 2004/04/03 4-1-5-1,-1-8-1,-2-2-1,-3-4-1,-3-5-1,-4-2-1, -5-4-2,-5-6-1,-6-2-1 4. _.doc 1
4 2004 4 3 2004/01/12 1 2004/01/23 2 I- - 10 2004/04/02 3-6 2004/04/03 4-1-5-1,-1-8-1,-2-2-1,-3-4-1,-3-5-1,-4-2-1, -5-4-2,-5-6-1,-6-2-1 4. _.doc 1 - - I. 4 I- 4 I- 4 I- 6 I- 6 I- 7 II. 8 II- 8 II- 8 II-
More information総合薬学講座 生物統計の基礎
2013 10 22 ( ) 2013 10 22 1 / 40 p.682 1. 2. 3 2 t Mann Whitney U ). 4 χ 2. 5. 6 Dunnett Tukey. 7. 8 Kaplan Meier.. U. ( ) 2013 10 22 2 / 40 1 93 ( 20 ) 230. a t b c χ 2 d 1.0 +1.0 e, b ( ) e ( ) ( ) 2013
More informationuntitled
23 12 10 12:55 ~ 18:45 KKR Tel0557-85-2000 FAX0557-85-6604 12:55~13:00 13:00~13:38 I 1) 13:00~13:12 2) 13:13~13:25 3) 13:26~13:38 13:39~14:17 II 4) 13:39~13:51 5) 13:52 ~ 14:04 6) 14:05 ~ 14:17 14:18 ~
More information1
10 1113 14 1516 1719 20 21 22 2324 25 2627 i 2829 30 31 32 33 3437 38 3941 42 4344 4547 48 4950 5152 53 5455 ii 56 5758 59 6061 iii 1 2 3 4 5 6 7 8 9 10 PFI 30 20 10 PFI 11 12 13 14 15 10 11 16 (1) 17
More information23 3 11 24 21 24 25 4 28 4 2 7 161 2,692 28 12 14 18 18 380 5 3 1 27 21 21 24 10,899 20,472 13,723 33,007 667 400 79,167 8,620 11,694 10,089 25,131 690 215 56,439 13,614 20,897 15,200 32,213 640 416 82,979
More informationo 2o 3o 3 1. I o 3. 1o 2o 31. I 3o PDF Adobe Reader 4o 2 1o I 2o 3o 4o 5o 6o 7o 2197/ o 1o 1 1o
78 2 78... 2 22201011... 4... 9... 7... 29 1 1214 2 7 1 8 2 2 3 1 2 1o 2o 3o 3 1. I 1124 4o 3. 1o 2o 31. I 3o PDF Adobe Reader 4o 2 1o 72 1. I 2o 3o 4o 5o 6o 7o 2197/6 9. 9 8o 1o 1 1o 2o / 3o 4o 5o 6o
More informationビットリアカップ2007けいはんなサイクルレースリザルト
Page 4/30 Page 5/30 Page 6/30 Page 7/30 Page 8/30 Page 9/30 Page 10/30 Page 11/30 Page 12/30 Page 13/30 Page 14/30 Page 15/30 Page 16/30 Page 17/30 Page 18/30 Page 19/30 Page 20/30 Page 21/30 Page 22/30
More informationPage 1
Page 1 Page 2 Page 3 Page 4 620 628 579-41 -6.7-49 -7.9 71 41 47-24 -33.3 6 15.9 11.5 6.5 8.1 36 15 22-14 -38.9 7 43.4 Page 5 277 302 23 24 12/3Q 12/4Q 13/1Q 13/2Q 13/3Q 13/4Q 14/1Q 14/2Q 14/3Q 14/4Q 15/1Q
More information印刷用一括
I.... - 2 -...- 2 -...- 2 -...- 2 -...- 3 -...- 4 -...- 6 - II.... - 7 - III.... - 9 -...- 9 -...- 15 -...- 20 -...- 22 -...- 28 - IV.... - 33 -...- 33 -...- 33 -...- 70 -...- 85 -...- 106 - V.... - 122
More information4 13 6 7 6 13 9 19
13 9 4 13 6 7 6 13 9 19 139 173 i 1 1 2 1 3 2 4 2 5 1 3 6 4 7 5 8 6 9 6 Q&A Q1 QA 9 Q2 9 Q3 10 Q4 11 Q5 11 Q6 11 Q7 12 Q8 12 ii Q9 12 Q101 13 Q102 13 Q11 17 Q12 18 Q13 18 Q14 19 Q15 19 Q16 20 Q17 20 Q18
More information276-E12001.indd
2012; 54 (6): 276 285 91.6% 1 1 91.6% 2 142 54 196 (1) (2) 6 (3) (4) 60 1 54.2% 91.6% 1 6,226,192 8,418,514 65,945 300,898 ROI 933% 2012; 54 (6): 276 285 doi: 10.1539/sangyoeisei.E12001 1,2) 2) 3) 3 5)
More information17. (1) 18. (1) 19. (1) 20. (1) 21. (1) (3) 22. (1) (3) 23. (1) (3) (1) (3) 25. (1) (3) 26. (1) 27. (1) (3) 28. (1) 29. (1) 2
1. (1) 2. 2 (1) 4. (1) 5. (1) 6. (1) 7. (1) 8. (1) 9. (1) 10. (1) 11. (1) 12. (1) 13. (1) 14. (1) 15. (1) (3) 16. (1) 1 17. (1) 18. (1) 19. (1) 20. (1) 21. (1) (3) 22. (1) (3) 23. (1) (3) 24. 1 (1) (3)
More information7... 1... 34... 55... 86... 108 15 2003 1 2 3 1 7 pdf 2 8 1996 2-1 9010 5 247 362 4 7 5 4 11 7 22 4 29 45 5 59 6 61 4 63 10 2 820 3 1646 19 1944 1 2 4 11 3 11 22 4 1 340 2 20 3 13 4 450 1 2 3 4 2-2 29
More informationこれわかWord2010_第1部_100710.indd
i 1 1 2 3 6 6 7 8 10 10 11 12 12 12 13 2 15 15 16 17 17 18 19 20 20 21 ii CONTENTS 25 26 26 28 28 29 30 30 31 32 35 35 35 36 37 40 42 44 44 45 46 49 50 50 51 iii 52 52 52 53 55 56 56 57 58 58 60 60 iv
More informationパワポカバー入稿用.indd
i 1 1 2 2 3 3 4 4 4 5 7 8 8 9 9 10 11 13 14 15 16 17 19 ii CONTENTS 2 21 21 22 25 26 32 37 38 39 39 41 41 43 43 43 44 45 46 47 47 49 52 54 56 56 iii 57 59 62 64 64 66 67 68 71 72 72 73 74 74 77 79 81 84
More informationこれでわかるAccess2010
i 1 1 1 2 2 2 3 4 4 5 6 7 7 9 10 11 12 13 14 15 17 ii CONTENTS 2 19 19 20 23 24 25 25 26 29 29 31 31 33 35 36 36 39 39 41 44 45 46 48 iii 50 50 52 54 55 57 57 59 61 63 64 66 66 67 70 70 73 74 74 77 77
More informationMajor Histocompatibility Complex 2018; 25 (2): 抄録集 2 HLA A 3 128
Major Histocompatibility Complex 2018; 25 (: 128 138 抄録集 2018 4 14 A 3 128 MHC 2018; 25 ( HLA 2013 10.5 10 8 12 10 8 2016 CD34 + HLA NC 10 8 CD34 + CD34 + 10 6 NC10.5 2013.Apr 2014.Mar NC11 2014.Apr 2016.Jun
More information(個別のテーマ) 放射線検査に関連した医療事故
- 131 - III - 132 - - 133 - III - 134 - - 135 - III - 136 - - 137 - III - 138 - - 139 - III - 140 - - 141 - III - 142 - - 143 - III - 144 - - 145 - III - 146 - - 147 - III - 148 - - 149 - III - 150 - -
More information(個別のテーマ) 薬剤に関連した医療事故
- 67 - III - 68 - - 69 - III - 70 - - 71 - III - 72 - - 73 - III - 74 - - 75 - III - 76 - - 77 - III - 78 - - 79 - III - 80 - - 81 - III - 82 - - 83 - III - 84 - - 85 - - 86 - III - 87 - III - 88 - - 89
More informationEV200R I II III 1 2 3 4 5 6 7 8 9 10 1 2 3 11 4 5 12 6 13 1 2 14 3 4 15 5 16 1 2 17 3 18 4 5 19 6 20 21 22 123 456 123 456 23 1 2 24 3 4 25 5 3 26 4 5 6 27 7 8 9 28 29 30 31 32 1 2 33 3 4 34 1 35 2 1
More informationÿþ
I O 01 II O III IV 02 II O 03 II O III IV III IV 04 II O III IV III IV 05 II O III IV 06 III O 07 III O 08 III 09 O III O 10 IV O 11 IV O 12 V O 13 V O 14 V O 15 O ( - ) ( - ) 16 本 校 志 望 の 理 由 入 学 後 の
More information訪問看護ステーションにおける安全性及び安定的なサービス提供の確保に関する調査研究事業報告書
1... 1 2... 3 I... 3 II... 3 1.... 3 2....15 3....17 4....19 5....25 6....34 7....38 8....48 9....58 III...70 3...73 I...73 1....73 2....82 II...98 4...99 1....99 2....104 3....106 4....108 5.... 110 6....
More information() 3 3 2 5 3 6 4 2 5 4 2 (; ) () 8 2 4 0 0 2 ex. 3 n n =, 2,, 20 : 3 2 : 9 3 : 27 4 : 8 5 : 243 6 : 729 7 : 287 8 : 656 9 : 9683 0 : 59049 : 7747 2 : 5344 3 : 594323 4 : 4782969 5 : 4348907 6 : 4304672
More information